Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10208354 NRG1 fusion genes in cancer

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Lynnette Fernandez-Cuesta0

Dennis Plenker0

Julie George0

Roman Thomas0

Date of Patent

February 19, 2019

Patent Application Number

14910639

Date Filed

August 7, 2014

Patent Citations Received

US Patent 11773170 Antibodies that bind EGFR and cMET

US Patent 11780925 ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene

Patent Primary Examiner

Patent abstract

The present invention relates to novel fusion genes comprising NRG1 and a further fusion partner, like CD74. The present invention provides for the use of these fusion genes in diagnosis as well as in medical intervention in cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10208354 NRG1 fusion genes in cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool